Accelerating research with a high quality real-world evidence platform

Analysis of real-world data - a valuable source

Providing key evidence base for clinical research and development

Analyses of real-world data expedite generation of research hypotheses that sharpen the focus of clinical research. Also, we solved one of the biggest hurdles, by easily matching patient populations with the right clinical trial, real-time and 24/7.

Market access - quality of information

Greater precision and clarity on the safety and efficacy of new drugs and medical devices
Improving the labeling and approved indications of products
Augment conventional randomised controlled trials
Faster market access

A better understanding of patient behaviours

Pre-regulatory approval

Real-world evidence analysis from patients' data whose diversity reflects real world practice, results in better insight on safe and effective use of innovations.

Greater precision and clarity on the safety and efficacy of new drugs and medical devices
Improving the labeling and approved indications of products
Augment conventional randomised controlled trials
Faster market access

Demonstrating ongoing safety and value

Value-based care support
Health economics and outcomes research studies
Regulatory collaboration
Longitudinal studies - generating new findings on the appropriate use and the value of innovations

Analysis of long-term patient outcomes

Post-regulatory approval

A continuous and a long-term examination of innovative and existing products and their impact on heterogeneous patient outcomes in real world settings, generates further insight on safety and efficacy and a better personalization of care. We provide data reports from risk-sharing agreements accelerating the rate at which products prove their value to patients, providers and payers.

Value-based care support
Health economics and outcomes research studies
Regulatory collaboration
Longitudinal studies - generating new findings on the appropriate use and the value of innovations